Allergan

Page 5 of 6

Views of The Facebook Inc. Logo Ahead of Earnings
Tech

VW’s New Horror And Facebook 3Q–5 Things To Know Today

By Laura Lorenzetti and Geoffrey Smith
November 4, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
Finance

Pfizer-Allergan could be a super inversion deal

By
October 29, 2015
Pershing Square Capital Management LP Founder And Chief Executive Officer William "Bill" Ackman
Features

Ackman’s back and Allergan — 5 things to know today

By Tom Huddleston Jr. and Geoffrey Smith
August 6, 2015
Brenton Saunders, David Pyott
Finance

From Actavis to Allergan: One pharma company’s wild dealmaking journey

By Stacy Jones, Kacy Burdette and Jen Wieczner
July 30, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
Finance

The real reasons for the pharma merger boom

By
July 28, 2015
Inside Teva Pharmaceuticals Headquarters
Commentary

Teva buys Allergan: 3 reasons why it’s a blockbuster deal

By
July 27, 2015
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO: How to survive an activist attack

By
February 12, 2015
IL: Corporations In Illinois
Finance

Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever

By
February 6, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

After Allergan loss, is Valeant dumpster diving?

By
January 31, 2015
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership

Step aside Wall Street, small pharma CEO pay reaches for the sky

By
January 5, 2015
Activist investors: The best (and worst) performers of 2014
Finance

Activist investors: The best (and worst) performers of 2014

By
December 3, 2014
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO hands Botox maker to lawyer instead of consultant

By
November 17, 2014
Botox
Finance

Actavis agrees to buy Botox-maker Allergan for $66 billion

By
November 17, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Zoetis shares spike on reported Ackman stake purchase

By
November 11, 2014
Did Bill Ackman just kill the poison pill?
Finance

Did Bill Ackman just kill the poison pill?

By
November 6, 2014

Most Popular